87 related articles for article (PubMed ID: 19967773)
1. Complications and risk factors of infection in pediatric hemato-oncology patients with totally implantable access ports (TIAPs).
Nam SH; Kim DY; Kim SC; Kim IK
Pediatr Blood Cancer; 2010 Apr; 54(4):546-51. PubMed ID: 19967773
[TBL] [Abstract][Full Text] [Related]
2. Reasons for explantation of totally implantable access ports: a multivariate analysis of 385 consecutive patients.
Fischer L; Knebel P; Schröder S; Bruckner T; Diener MK; Hennes R; Buhl K; Schmied B; Seiler CM
Ann Surg Oncol; 2008 Apr; 15(4):1124-9. PubMed ID: 18214621
[TBL] [Abstract][Full Text] [Related]
3. [Central venous totally implantable access for high dose chemotherapy in children].
Conter C; Carausu L; Martin E; Rubie H; Castex MP; Marec-Berard P
Arch Pediatr; 2006 Mar; 13(3):256-61. PubMed ID: 16469486
[TBL] [Abstract][Full Text] [Related]
4. An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction.
Ignatov A; Hoffman O; Smith B; Fahlke J; Peters B; Bischoff J; Costa SD
Eur J Surg Oncol; 2009 Mar; 35(3):241-6. PubMed ID: 18329836
[TBL] [Abstract][Full Text] [Related]
5. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients.
Adler A; Yaniv I; Steinberg R; Solter E; Samra Z; Stein J; Levy I
J Hosp Infect; 2006 Mar; 62(3):358-65. PubMed ID: 16377030
[TBL] [Abstract][Full Text] [Related]
6. Radiologic placement of a low profile implantable venous access port in a pediatric population.
Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
[TBL] [Abstract][Full Text] [Related]
7. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients.
Samaras P; Dold S; Braun J; Kestenholz P; Breitenstein S; Imhof A; Renner C; Stenner-Liewen F; Pestalozzi BC
Oncology; 2008; 74(3-4):237-44. PubMed ID: 18716418
[TBL] [Abstract][Full Text] [Related]
8. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
[TBL] [Abstract][Full Text] [Related]
9. Surgical technique for totally implantable access ports (TIAP) needs improvement: a multivariate analysis of 400 patients.
Seiler CM; Frohlich BE; Dorsam UJ; Kienle P; Buchler MW; Knaebel HP
J Surg Oncol; 2006 Jan; 93(1):24-9. PubMed ID: 16353193
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for early catheter-related infections in cancer patients.
Penel N; Neu JC; Clisant S; Hoppe H; Devos P; Yazdanpanah Y
Cancer; 2007 Oct; 110(7):1586-92. PubMed ID: 17685401
[TBL] [Abstract][Full Text] [Related]
11. Central venous access ports in children treated for hematopoietic malignancies.
Bucki B; Tomaszewska R; Karpe J; Stoksik P; Sońta-Jakimczyk D; Szczepański T
Pediatr Hematol Oncol; 2008 Dec; 25(8):751-5. PubMed ID: 19065441
[TBL] [Abstract][Full Text] [Related]
12. Totally implantable central venous access devices in children with hemato-oncologic malignancies: evaluation of complications and comparison of incidence of febrile episodes with similar patients without central venous access devices.
Sarper N; Zengin E; Corapçioglu F; Tugay M
Pediatr Hematol Oncol; 2006 Sep; 23(6):459-70. PubMed ID: 16849276
[TBL] [Abstract][Full Text] [Related]
13. Risk factor analysis of permanent pacemaker infection.
Sohail MR; Uslan DZ; Khan AH; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Stoner SM; Baddour LM
Clin Infect Dis; 2007 Jul; 45(2):166-73. PubMed ID: 17578774
[TBL] [Abstract][Full Text] [Related]
14. Complications of total implantable access ports and efficacy of Taurolidine-citrate lock solution against catheter-related infections.
Ince E; Oğuzkurt P; Temiz A; Ezer SS; Gezer HÖ; Yazici N; Hiçsönmez A
Afr J Paediatr Surg; 2014; 11(2):138-42. PubMed ID: 24841014
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneously implanted central venous access device infection in pediatric patients with cancer.
Hung MC; Chen CJ; Wu KG; Hung GY; Lin YJ; Tang RB
J Microbiol Immunol Infect; 2009 Apr; 42(2):166-71. PubMed ID: 19597650
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.
Schwarz RE; Groeger JS; Coit DG
Cancer; 1997 Apr; 79(8):1635-40. PubMed ID: 9118051
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic urokinase in the management of long-term venous access devices in children: a Children's Oncology Group study.
Dillon PW; Jones GR; Bagnall-Reeb HA; Buckley JD; Wiener ES; Haase GM;
J Clin Oncol; 2004 Jul; 22(13):2718-23. PubMed ID: 15226339
[TBL] [Abstract][Full Text] [Related]
18. Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis.
Heibl C; Trommet V; Burgstaller S; Mayrbaeurl B; Baldinger C; Koplmüller R; Kühr T; Wimmer L; Thaler J
Eur J Cancer Care (Engl); 2010 Sep; 19(5):676-81. PubMed ID: 19708941
[TBL] [Abstract][Full Text] [Related]
19. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients.
Ross MN; Haase GM; Poole MA; Burrington JD; Odom LF
Surg Gynecol Obstet; 1988 Aug; 167(2):141-4. PubMed ID: 3400032
[TBL] [Abstract][Full Text] [Related]
20. [Long-term central venous access in oncology. Review of a caseload of 750 cases].
Bertoglio S; Meszsaros P; Disomma C; Moresco L; Cafiero F; Gipponi M; Percivale P
Minerva Chir; 1996 Jun; 51(6):427-31. PubMed ID: 8992390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]